RVMD Annual SG&A
$75.62 M
+$35.03 M+86.32%
31 December 2023
Summary:
As of January 22, 2025, RVMD annual selling, general & administrative expenses is $75.62 million, with the most recent change of +$35.03 million (+86.32%) on December 31, 2023. During the last 3 years, it has risen by +$54.19 million (+252.91%). RVMD annual SG&A is now at all-time high.RVMD Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVMD Quarterly SG&A
$23.96 M
+$2.25 M+10.36%
30 September 2024
Summary:
As of January 22, 2025, RVMD quarterly selling, general & administrative expenses is $23.96 million, with the most recent change of +$2.25 million (+10.36%) on September 30, 2024. Over the past year, it has increased by +$1.12 million (+4.91%). RVMD quarterly SG&A is now -25.69% below its all-time high of $32.24 million, reached on December 31, 2023.RVMD Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVMD TTM SG&A
-$5.32 B
-$567.06 M-11.93%
30 September 2024
Summary:
As of January 22, 2025, RVMD TTM selling, general & administrative expenses is -$5.32 billion, with the most recent change of -$567.06 million (-11.93%) on September 30, 2024. Over the past year, it has dropped by -$5.41 billion (-6343.44%). RVMD TTM SG&A is now -4750.07% below its all-time high of $100.75 million, reached on September 30, 2024.RVMD TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVMD Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +86.3% | +4.9% | -6343.4% |
| 3 y3 years | +252.9% | +207.5% | -10000.0% |
| 5 y5 years | +703.6% | +311.3% | -10000.0% |
RVMD Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +148.3% | -25.7% | +175.7% | -254.2% | at low |
| 5 y | 5-year | at high | +509.6% | -25.7% | +475.7% | -1672.8% | at low |
| alltime | all time | at high | +1564.6% | -25.7% | +891.7% | -4750.1% | at low |
Revolution Medicines Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $23.96 M(+10.4%) | $100.75 M(+9.2%) |
| June 2024 | - | $21.71 M(-4.9%) | $92.31 M(+8.3%) |
| Mar 2024 | - | $22.84 M(-29.2%) | $85.23 M(+12.7%) |
| Dec 2023 | $75.62 M(+86.3%) | $32.24 M(+107.9%) | $75.62 M(+39.3%) |
| Sept 2023 | - | $15.51 M(+6.0%) | $54.29 M(+10.3%) |
| June 2023 | - | $14.64 M(+10.7%) | $49.21 M(+9.9%) |
| Mar 2023 | - | $13.22 M(+21.2%) | $44.77 M(+10.3%) |
| Dec 2022 | $40.59 M(+33.3%) | $10.91 M(+4.6%) | $40.59 M(+5.8%) |
| Sept 2022 | - | $10.43 M(+2.3%) | $38.37 M(+7.4%) |
| June 2022 | - | $10.20 M(+12.9%) | $35.72 M(+8.9%) |
| Mar 2022 | - | $9.04 M(+4.0%) | $32.82 M(+7.8%) |
| Dec 2021 | $30.45 M | $8.69 M(+11.6%) | $30.45 M(+10.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $7.79 M(+6.8%) | $27.58 M(+9.7%) |
| June 2021 | - | $7.30 M(+9.4%) | $25.13 M(+9.6%) |
| Mar 2021 | - | $6.67 M(+14.5%) | $22.93 M(+7.0%) |
| Dec 2020 | $21.43 M(+72.7%) | $5.83 M(+9.1%) | $21.43 M(+8.4%) |
| Sept 2020 | - | $5.34 M(+4.9%) | $19.77 M(+12.8%) |
| June 2020 | - | $5.09 M(-1.5%) | $17.53 M(+15.6%) |
| Mar 2020 | - | $5.17 M(+24.2%) | $15.16 M(+22.2%) |
| Dec 2019 | $12.41 M(+31.8%) | $4.16 M(+34.1%) | $12.41 M(+2.7%) |
| Sept 2019 | - | $3.10 M(+13.9%) | $12.08 M(+34.6%) |
| June 2019 | - | $2.73 M(+12.8%) | $8.98 M(+43.6%) |
| Mar 2019 | - | $2.42 M(-37.0%) | $6.25 M(+63.0%) |
| Dec 2018 | $9.41 M(+107.1%) | $3.83 M | $3.83 M |
| Dec 2017 | $4.54 M | - | - |
FAQ
- What is Revolution Medicines annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Revolution Medicines?
- What is Revolution Medicines annual SG&A year-on-year change?
- What is Revolution Medicines quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Revolution Medicines?
- What is Revolution Medicines quarterly SG&A year-on-year change?
- What is Revolution Medicines TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Revolution Medicines?
- What is Revolution Medicines TTM SG&A year-on-year change?
What is Revolution Medicines annual selling, general & administrative expenses?
The current annual SG&A of RVMD is $75.62 M
What is the all time high annual SG&A for Revolution Medicines?
Revolution Medicines all-time high annual selling, general & administrative expenses is $75.62 M
What is Revolution Medicines annual SG&A year-on-year change?
Over the past year, RVMD annual selling, general & administrative expenses has changed by +$35.03 M (+86.32%)
What is Revolution Medicines quarterly selling, general & administrative expenses?
The current quarterly SG&A of RVMD is $23.96 M
What is the all time high quarterly SG&A for Revolution Medicines?
Revolution Medicines all-time high quarterly selling, general & administrative expenses is $32.24 M
What is Revolution Medicines quarterly SG&A year-on-year change?
Over the past year, RVMD quarterly selling, general & administrative expenses has changed by +$1.12 M (+4.91%)
What is Revolution Medicines TTM selling, general & administrative expenses?
The current TTM SG&A of RVMD is -$5.32 B
What is the all time high TTM SG&A for Revolution Medicines?
Revolution Medicines all-time high TTM selling, general & administrative expenses is $100.75 M
What is Revolution Medicines TTM SG&A year-on-year change?
Over the past year, RVMD TTM selling, general & administrative expenses has changed by -$5.41 B (-6343.44%)